Menard Financial Group LLC Amgen Inc Transaction History

Menard Financial Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $512,419 - $600,361	-2,414 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $33,869 - $37,575	-145 Reduced 5.67%	2,414 $588,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $55,699 - $64,908	-251 Reduced 8.93%	2,559 $637,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $97,154 - $115,693	-449 Reduced 13.78%	2,810 $646,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $95,267 - $105,945	406 Added 14.23%	3,259 $828,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $564,351 - $692,537	2,853 New	2,853 $673,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $367,395 - $487,267	-2,016 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $381,447 - $490,291	2,016 New	2,016 $486,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Menard Financial Group LLC with notifications on news.